{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:44:18Z","timestamp":1791935058372,"version":"4.3.4"},"reference-count":41,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2021]]},"DOI":"10.3201\/eid2706.204238","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T09:07:54Z","timestamp":1621415274000},"page":"1627-1636","source":"Crossref","is-referenced-by-count":70,"title":["Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children"],"prefix":"10.3201","volume":"27","author":[{"given":"Matt","family":"Wasserman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotem","family":"Lapidot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Dillon-Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Chilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2706.204238-202105162226-R1","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","author":"Advisory Committee on Immunization Practices","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2706.204238-202105162226-R2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/infdis\/148.1.131","article-title":"Antibody response to pneumococcal vaccination in children younger than five years of age.","volume":"148","author":"Douglas","year":"1983","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2706.204238-202105162226-R3","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998-2003.","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2706.204238-202105162226-R4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/599827","article-title":"Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.","volume":"49","author":"Kellner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2706.204238-202105162226-R5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children.","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2706.204238-202105162226-R6","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1016\/j.vaccine.2007.04.088","article-title":"Herd immunity and pneumococcal conjugate vaccine: a quantitative model.","volume":"25","author":"Haber","year":"2007","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2706.204238-202105162226-R8","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/S0264-410X(00)00283-8","article-title":"Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.","volume":"19","author":"Eskola","year":"2000","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1471-2334-12-175","article-title":"Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data.","volume":"12","author":"Strutton","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2706.204238-202105162226-R10","first-page":"988","article-title":"National, state, and urban area vaccination coverage among children aged 19-35 months\u2014United States, 2005.","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2706.204238-202105162226-R11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.7326\/M20-2726","article-title":"Postmarketing safety of vaccines approved by the U.S. Food and Drug Administration: a cohort study.","volume":"173","author":"Tau","year":"2020","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2706.204238-202105162226-R12","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core surveillance: surveillance reports. 2020 [cited 2020 Feb 29]. https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html"},{"key":"key-10.3201\/eid2706.204238-202105162226-R13","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1016\/j.vaccine.2020.08.068","article-title":"Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis.","volume":"38","author":"Chapman","year":"2020","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2706.204238-202105162226-R15","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1097\/INF.0000000000000082","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.","volume":"33","author":"Loo","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2706.204238-202105162226-R16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/CMR.00018-12","article-title":"Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.","volume":"25","author":"Tan","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid2706.204238-202105162226-R17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1080\/14760584.2019.1676155","article-title":"The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review.","volume":"18","author":"Tin Tin Htar","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"key-10.3201\/eid2706.204238-202105162226-R18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","article-title":"The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.","volume":"30","author":"Myint","year":"2013","journal-title":"Adv Ther"},{"key":"key-10.3201\/eid2706.204238-202105162226-R19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3810\/pgm.2013.11.2710","article-title":"The changing microbiologic epidemiology of community-acquired pneumonia.","volume":"125","author":"Aliberti","year":"2013","journal-title":"Postgrad Med"},{"key":"key-10.3201\/eid2706.204238-202105162226-R20","doi-asserted-by":"publisher","first-page":"C26","DOI":"10.1016\/j.vaccine.2011.06.104","article-title":"Prevenar experience.","volume":"29","author":"Arguedas","year":"2011","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R21","doi-asserted-by":"publisher","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2706.204238-202105162226-R22","unstructured":"United States Census Bureau. Population and housing unit estimates tables. 2020 [cited 2020 Mar 1]. https:\/\/www.census.gov\/programs-surveys\/popest\/data\/tables.html"},{"key":"key-10.3201\/eid2706.204238-202105162226-R23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijporl.2019.01.023","article-title":"National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5\u202fyears in the United States.","volume":"119","author":"Zhou","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"key-10.3201\/eid2706.204238-202105162226-R24","doi-asserted-by":"publisher","first-page":"e00309","DOI":"10.1128\/mBio.00309-10","article-title":"Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.","volume":"2","author":"Simonsen","year":"2011","journal-title":"MBio"},{"key":"key-10.3201\/eid2706.204238-202105162226-R25","doi-asserted-by":"publisher","first-page":"29256","DOI":"10.3402\/ijch.v74.29256","article-title":"Lower respiratory tract infection hospitalizations among American Indian\/Alaska Native children and the general United States child population.","volume":"74","author":"Foote","year":"2015","journal-title":"Int J Circumpolar Health"},{"key":"key-10.3201\/eid2706.204238-202105162226-R26","first-page":"1","article-title":"Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine\u2014United States, 1997-2006.","volume":"58","author":"Grijalva","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2706.204238-202105162226-R27","unstructured":"Lessa FC, Spiller MT, Soda E, Weinberger D, Griffin MR, Grijalva CG,  Impact of introduction of infant vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) on pneumonia and invasive pneumococcal disease (IPD) hospitalizations in the United States, 2005\u20132014. Presented at: 11th International Symposium on Pneumococci and Pneumococcal Diseases; 2018 Apr 15\u201319: Melbourne, Victoria, Australia."},{"key":"key-10.3201\/eid2706.204238-202105162226-R28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1186\/s12913-018-3529-4","article-title":"Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014.","volume":"18","author":"Tong","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"key-10.3201\/eid2706.204238-202105162226-R29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"key-10.3201\/eid2706.204238-202105162226-R30","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.vaccine.2005.01.132","article-title":"Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults.","volume":"24","author":"Black","year":"2006","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R31","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1016\/j.vaccine.2017.05.077","article-title":"Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts\u2019 children to relatively low invasiveness.","volume":"35","author":"Yildirim","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamapediatrics.2013.3924","article-title":"Trends in otitis media-related health care use in the United States, 2001-2011.","volume":"168","author":"Marom","year":"2014","journal-title":"JAMA Pediatr"},{"key":"key-10.3201\/eid2706.204238-202105162226-R33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12913-018-3139-1","article-title":"Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008-2014.","volume":"18","author":"Tong","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"key-10.3201\/eid2706.204238-202105162226-R34","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1016\/j.vaccine.2009.08.045","article-title":"Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.","volume":"27","author":"Ray","year":"2009","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.vaccine.2009.10.121","article-title":"Declining invasive pneumococcal disease mortality in the United States, 1990-2005.","volume":"28","author":"Pulido","year":"2010","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R36","unstructured":"World Health Organization. Estimated Hib and pneumococcal deaths for children under 5 years of age, 2000. 2014 [cited 2020 Mar 1]. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/estimates\/Pneumo_hib\/en"},{"key":"key-10.3201\/eid2706.204238-202105162226-R37","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jval.2019.06.011","article-title":"Pneumococcal disease: a systematic review of health utilities, resource use, costs, and economic evaluations of interventions.","volume":"22","author":"Shiri","year":"2019","journal-title":"Value Health"},{"key":"key-10.3201\/eid2706.204238-202105162226-R38","doi-asserted-by":"crossref","unstructured":"Dagan R, Ben-Shimol S, Greenberg D, Givon-Lavi N. A prospective, population-based study to determine the incidence and bacteriology of bacterial conjunctivitis in children <2 years following PCV7\/PCV13 sequential implementation. Clin Infect Dis. 2020 Mar 4 [Epub ahead of print].","DOI":"10.1093\/cid\/ciaa197"},{"key":"key-10.3201\/eid2706.204238-202105162226-R39","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.vaccine.2016.04.043","article-title":"The impact of pneumococcal conjugate vaccines on carriage of and disease caused by Streptococcus pneumoniae serotypes 6C and 6D in southern Israel.","volume":"34","author":"Porat","year":"2016","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2706.204238-202105162226-R40","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1080\/21645515.2018.1476814","article-title":"The role of vaccines in fighting antimicrobial resistance (AMR).","volume":"14","author":"Jansen","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2706.204238-202105162226-R41","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1080\/21645515.2018.1470726","article-title":"Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them.","volume":"14","author":"Wantuch","year":"2018","journal-title":"Hum Vaccin Immunother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/6\/20-4238_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:52:12Z","timestamp":1732971132000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/6\/20-4238_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2706.204238","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}